Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02912754
Title Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
Sunnybrook Odette Cancer Center Toronto Ontario M4N 3M5 Canada Details
Sunnybrook Odette Cancer Center Toronto Ontario M4N3M5 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field